Modulation of macrophage gene expression via liver X receptor α serine 198 phosphorylation

Molecular and Cellular Biology

Volumn 35, Issue 11, 2015, Pages 2024-2034

  Wu, Chaowei ^a   Hussein, Maryem A ^a   Shrestha, Elina ^a   Leone, Sarah ^a   Aiyegbo, Mohammed S ^a   Lambert, W Marcus ^a,d   Pourcet, Benoit ^b,e   Cardozo, Timothy ^a   Gustafson, Jan Ake ^c   Fisher, Edward A ^a   Pineda Torra, Ines ^b   Garabedian, Michael J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c University of Houston   (United States)

^d Weill Cornell Medical Center   (United States)

^e Department of Medicine Division of Cardiology Mark and Ruti Bell Program in Vascular Biology New York University School of Medicine ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR7; CXCL14 CHEMOKINE; DNA; HISTONE H3; LIVER X RECEPTOR ALPHA; LYMPHOTOXIN BETA; MESSENGER RNA; SERINE; LIGAND; LIVER X RECEPTOR; ORPHAN NUCLEAR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW DERIVED MACROPHAGE; CELL ACTIVATION; CELL ADHESION; CHROMATIN IMMUNOPRECIPITATION; CONFORMATIONAL TRANSITION; CYTOKINE PRODUCTION; ENDOCYTOSIS; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; HINGE REGION; HISTONE MODIFICATION; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MOLECULAR MODEL; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; WILD TYPE; ANIMAL; ATHEROSCLEROSIS; C57BL MOUSE; CELL LINE; GENETICS; HUMAN; METABOLISM; PHOSPHORYLATION;

ANIMALS; ATHEROSCLEROSIS; CELL LINE; GENE EXPRESSION; HUMANS; LIGANDS; MACROPHAGES; MICE; MICE, INBRED C57BL; ORPHAN NUCLEAR RECEPTORS; PHOSPHORYLATION; RECEPTORS, CCR7; SERINE;

EID: 84929400878     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00985-14     Document Type: Article

References (55)

1. Calkin AC, Tontonoz P. 2012. Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR. Nat Rev Mol Cell Biol 13:213-224. http://dx.doi.org/10.1038/nrm3312.
2. Im SS, Osborne TF. 2011. Liver x receptors in atherosclerosis and inflammation. Circ Res 108:996-1001. http://dx.doi.org/10.1161/CIRCRESAHA.110.226878.
3. Moore KJ, Sheedy FJ, Fisher EA. 2013. Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol 13:709-721. http://dx.doi.org/10.1038/nri3520.
4. Trogan E, Feig JE, Dogan S, Rothblat GH, Angeli V, Tacke F, Randolph GJ, Fisher EA. 2006. Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoEdeficient mice. Proc Natl Acad Sci U S A 103:3781-3786. http://dx.doi.org/10.1073/pnas.0511043103.
5. Feig JE, Rong JX, Shamir R, Sanson M, Vengrenyuk Y, Liu J, Rayner K, Moore K, Garabedian M, Fisher EA. 2011. HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells. Proc Natl Acad Sci U S A 108:7166-7171. http://dx.doi.org/10.1073/pnas.1016086108.
6. Randolph GJ. 2014. Mechanisms that regulate macrophage burden in atherosclerosis. Circ Res 114:1757-1771. http://dx.doi.org/10.1161/CIRCRESAHA.114.301174.
7. Feig JE, Pineda-Torra I, Sanson M, Bradley MN, Vengrenyuk Y, Bogunovic D, Gautier EL, Rubinstein D, Hong C, Liu J, Wu C, van Rooijen N, Bhardwaj N, Garabedian M, Tontonoz P, Fisher EA. 2010. LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression. J Clin Invest 120:4415-4424. http://dx.doi.org/10.1172/JCI38911.
8. Peet DJ, Turley SD, Ma W, Janowski BA, Lobaccaro JM, Hammer RE, Mangelsdorf DJ. 1998. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 93:693-704. http://dx.doi.org/10.1016/S0092-8674(00)81432-4.
9. Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ. 1996. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 383:728-731. http://dx.doi.org/10.1038/383728a0.
10. Yang C, McDonald JG, Patel A, Zhang Y, Umetani M, Xu F, Westover EJ, Covey DF, Mangelsdorf DJ, Cohen JC, Hobbs HH. 2006. Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands. J Biol Chem 281:27816-27826. http://dx.doi.org/10.1074/jbc.M603781200.
11. Wagner BL, Valledor AF, Shao G, Daige CL, Bischoff ED, Petrowski M, Jepsen K, Baek SH, Heyman RA, Rosenfeld MG, Schulman IG, Glass CK. 2003. Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression. Mol Cell Biol 23:5780-5789. http://dx.doi.org/10.1128/MCB.23.16.5780-5789.2003.
12. Calkin AC, Tontonoz P. 2010. Liver x receptor signaling pathways and atherosclerosis. Arterioscler Thromb Vasc Biol 30:1513-1518. http://dx.doi.org/10.1161/ATVBAHA.109.191197.
13. Venkateswaran A, Laffitte BA, Joseph SB, Mak PA, Wilpitz DC, Edwards PA, Tontonoz P. 2000. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc Natl Acad Sci USA 97:12097-12102. http://dx.doi.org/10.1073/pnas.200367697.
14. Laffitte BA, Repa JJ, Joseph SB, Wilpitz DC, Kast HR, Mangelsdorf DJ, Tontonoz P. 2001. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc Natl Acad Sci U S A 98:507-512. http://dx.doi.org/10.1073/pnas.98.2.507.
15. Levin N, Bischoff ED, Daige CL, Thomas D, Vu CT, Heyman RA, Tangirala RK, Schulman IG. 2005. Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists. Arterioscler Thromb Vasc Biol 25:135-142. http://dx.doi.org/10.1161/01.ATV.0000150044.84012.68.
16. Verschuren L, de Vries-van der Weij J, Zadelaar S, Kleemann R, Kooistra T. 2009. LXR agonist suppresses atherosclerotic lesion growth and promotes lesion regression in apoE*3Leiden mice: time course and mechanisms. J Lipid Res 50:301-311. http://dx.doi.org/10.1194/jlr.M800374-JLR200.
17. Bischoff ED, Daige CL, Petrowski M, Dedman H, Pattison J, Juliano J, Li AC, Schulman IG. 2010. Non-redundant roles for LXRalpha and LXRbeta in atherosclerosis susceptibility in low density receptor knockout mice. J Lipid Res 51:900-906. http://dx.doi.org/10.1194/jlr.M900096.
18. Chen M, Bradley MN, Beaven SW, Tontonoz P. 2006. Phosphorylation of the liver X receptors. FEBS Lett 580:4835-4841. http://dx.doi.org/10.1016/j.febslet.2006.07.074.
19. Yamamoto T, Shimano H, Inoue N, Nakagawa Y, Matsuzaka T, Takahashi A, Yahagi N, Sone H, Suzuki H, Toyoshima H, Yamada N. 2007. Protein kinase A suppresses sterol regulatory element-binding protein-1C expression via phosphorylation of liver X receptor in the liver. J Biol Chem 282:11687-11695. http://dx.doi.org/10.1074/jbc.M611911200.
20. Torra IP, Ismaili N, Feig JE, Xu CF, Cavasotto C, Pancratov R, Rogatsky I, Neubert TA, Fisher EA, Garabedian MJ. 2008. Phosphorylation of liver X receptor alpha selectively regulates target gene expression in macrophages. Mol Cell Biol 28:2626-2636. http://dx.doi.org/10.1128/MCB.01575-07.
21. Alberti S, Schuster G, Parini P, Feltkamp D, Diczfalusy U, Rudling M, Angelin B, Bjorkhem I, Pettersson S, Gustafsson JA. 2001. Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice. J Clin Invest 107:565-573. http://dx.doi.org/10.1172/JCI9794.
22. Reily MM, Pantoja C, Hu X, Chinenov Y, Rogatsky I. 2006. The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression. EMBO J 25:108-117. http://dx.doi.org/10.1038/sj.emboj.7600919.
23. Lou X, Toresson G, Benod C, Suh JH, Philips KJ, Webb P, Gustafsson JA. 2014. Structure of the retinoid X receptor alpha-liver X receptor beta (RXRalpha-LXRbeta) heterodimer on DNA. Nat Struct Mol Biol 21:277-281. http://dx.doi.org/10.1038/nsmb.2778.
24. Abagyan R, Batalov S, Cardozo T, Totrov M, Webber J, Zhou Y. 1997. Homology modeling with internal coordinate mechanics: deformation zone mapping and improvements of models via conformational search. Proteins (Suppl 1) 1997:29-37.
25. Cardozo T, Totrov M, Abagyan R. 1995. Homology modeling by the ICM method. Proteins 23:403-414. http://dx.doi.org/10.1002/prot.340230314.
26. Arnautova YA, Abagyan RA, Totrov M. 2011. Development of a new physics-based internal coordinate mechanics force field and its application to protein loop modeling. Proteins 79:477-498. http://dx.doi.org/10.1002/prot.22896.
27. Abagyan R, Totrov M. 1994. Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins. J Mol Biol 235:983-1002. http://dx.doi.org/10.1006/jmbi.1994.1052.
28. Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, Alvarez P, Brockman W, Kim TK, Koche RP, Lee W, Mendenhall E, O'Donovan A, Presser A, Russ C, Xie X, Meissner A, Wernig M, Jaenisch R, Nusbaum C, Lander ES, Bernstein BE. 2007. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448:553-560. http://dx.doi.org/10.1038/nature06008.
29. Feig JE, Parathath S, Rong JX, Mick SL, Vengrenyuk Y, Grauer L, Young SG, Fisher EA. 2011. Reversal of hyperlipidemia with a genetic switch favorably affects the content and inflammatory state of macrophages in atherosclerotic plaques. Circulation 123:989-998. http://dx.doi.org/10.1161/CIRCULATIONAHA.110.984146.
30. Green TD, Park J, Yin Q, Fang S, Crews AL, Jones SL, Adler KB. 2012. Directed migration of mouse macrophages in vitro involves myristoylated alanine-rich C-kinase substrate (MARCKS) protein. J Leukoc Biol 92: 633-639. http://dx.doi.org/10.1189/jlb.1211604.
31. Rajapakse S, Ogiwara K, Takano N, Moriyama A, Takahashi T. 2005. Biochemical characterization of human kallikrein 8 and its possible involvement in the degradation of extracellular matrix proteins. FEBS Lett 579:6879-6884. http://dx.doi.org/10.1016/j.febslet.2005.11.039.
32. Choi EY, Chavakis E, Czabanka MA, Langer HF, Fraemohs L, Economopoulou M, Kundu RK, Orlandi A, Zheng YY, Prieto DA, Ballantyne CM, Constant SL, Aird WC, Papayannopoulou T, Gahmberg CG, Udey MC, Vajkoczy P, Quertermous T, Dimmeler S, Weber C, Chavakis T. 2008. Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment. Science 322:1101-1104. http://dx.doi.org/10.1126/science.1165218.
33. Morris SM, Arden SD, Roberts RC, Kendrick-Jones J, Cooper JA, Luzio JP, Buss F. 2002. Myosin VI binds to and localises with Dab2, potentially linking receptor-mediated endocytosis and the actin cytoskeleton. Traffic 3:331-341. http://dx.doi.org/10.1034/j.1600-0854.2002.30503.x.
34. Ma G, Pan PY, Eisenstein S, Divino CM, Lowell CA, Takai T, Chen SH. 2011. Paired immunoglobin-like receptor-B regulates the suppressive function and fate of myeloid-derived suppressor cells. Immunity 34:385-395. http://dx.doi.org/10.1016/j.immuni.2011.02.004.
35. Hara T, Tanegashima K. 2012. Pleiotropic functions of the CXC-type chemokine CXCL14 in mammals. J Biochem 151:469-476. http://dx.doi.org/10.1093/jb/mvs030.
36. Grandoch M, Feldmann K, Gothert JR, Dick LS, Homann S, Bayer JK, Klatt C, Waldheim JN, Rabausch B, Nagy N, Oberhuber A, Deenen R, Kohrer K, Lehr S, Homey B, Pfeffer K, Fischer JW. 4 March 2015, posting date. Deficiency in lymphotoxin beta receptor protects from atherosclerosis in apoE-deficient mice. Circ Res http://dx.doi.org/10.1161/CIRCRESAHA.116.305723.
37. Zuk PA, Elferink LA. 2000. Rab15 differentially regulates early endocytic trafficking. J Biol Chem 275:26754-26764.
38. Rudd ML, Nicolas AN, Brown BL, Fischer-Stenger K, Stewart JK. 2005. Peritoneal macrophages express the serotonin transporter. J Neuroimmunol 159:113-118. http://dx.doi.org/10.1016/j.jneuroim.2004.10.013.
39. Gerstein MB, Kundaje A, Hariharan M, Landt SG, Yan KK, Cheng C, Mu XJ, Khurana E, Rozowsky J, Alexander R, Min R, Alves P, Abyzov A, Addleman N, Bhardwaj N, Boyle AP, Cayting P, Charos A, Chen DZ, Cheng Y, Clarke D, Eastman C, Euskirchen G, Frietze S, Fu Y, Gertz J, Grubert F, Harmanci A, Jain P, Kasowski M, Lacroute P, Leng J, Lian J, Monahan H, O'Geen H, Ouyang Z, Partridge EC, Patacsil D, Pauli F, Raha D, Ramirez L, Reddy TE, Reed B, Shi M, Slifer T, Wang J, Wu L, Yang X, Yip KY, Zilberman-Schapira G, et al. 2012. Architecture of the human regulatory network derived from ENCODE data. Nature 489:91-100. http://dx.doi.org/10.1038/nature11245.
40. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, Glass CK. 2010. Simple combinations of lineagedetermining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38:576-589. http://dx.doi.org/10.1016/j.molcel.2010.05.004.
41. Pourcet B, Feig JE, Vengrenyuk Y, Hobbs AJ, Kepka-Lenhart D, Garabedian MJ, Morris SM, Jr, Fisher EA, Pineda-Torra I. 2011. LXRalpha regulates macrophage arginase 1 through PU.1 and interferon regulatory factor 8. Circ Res 109:492-501. http://dx.doi.org/10.1161/CIRCRESAHA.111.241810.
42. Feig JE, Vengrenyuk Y, Reiser V, Wu C, Statnikov A, Aliferis CF, Garabedian MJ, Fisher EA, Puig O. 2012. Regression of atherosclerosis is characterized by broad changes in the plaque macrophage transcriptome. PLoS One 7:e39790. http://dx.doi.org/10.1371/journal.pone.0039790.
43. Williams HJ, Fisher EA, Greaves DR. 2012. Macrophage differentiation and function in atherosclerosis: opportunities for therapeutic intervention? J Innate Immun 4:498-508. http://dx.doi.org/10.1159/000336618.
44. Chandra V, Huang P, Hamuro Y, Raghuram S, Wang Y, Burris TP, Rastinejad F. 2008. Structure of the intact PPAR-gamma-RXR-alpha nuclear receptor complex on DNA. Nature 456:350-356. http://dx.doi.org/10.1038/nature07413.
45. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N. 2012. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2:401-404. http://dx.doi.org/10.1158/2159-8290.CD-12-0095.
46. Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, Cerami E, Sander C, Schultz N. 2013. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6:pl1.
47. Pehkonen P, Welter-Stahl L, Diwo J, Ryynanen J, Wienecke-Baldacchino A, Heikkinen S, Treuter E, Steffensen KR, Carlberg C. 2012. Genome-wide landscape of liver X receptor chromatin binding and gene regulation in human macrophages. BMC Genomics 13:50. http://dx.doi.org/10.1186/1471-2164-13-50.
48. Boergesen M, Pedersen TA, Gross B, van Heeringen SJ, Hagenbeek D, Bindesboll C, Caron S, Lalloyer F, Steffensen KR, Nebb HI, Gustafsson JA, Stunnenberg HG, Staels B, Mandrup S. 2012. Genome-wide profiling of liver X receptor, retinoid X receptor, and peroxisome proliferator-activated receptor alpha in mouse liver reveals extensive sharing of binding sites. Mol Cell Biol 32:852-867. http://dx.doi.org/10.1128/MCB.06175-11.
49. Landt SG, Marinov GK, Kundaje A, Kheradpour P, Pauli F, Batzoglou S, Bernstein BE, Bickel P, Brown JB, Cayting P, Chen Y, DeSalvo G, Epstein C, Fisher-Aylor KI, Euskirchen G, Gerstein M, Gertz J, Hartemink AJ, Hoffman MM, Iyer VR, Jung YL, Karmakar S, Kellis M, Kharchenko PV, Li Q, Liu T, Liu XS, Ma L, Milosavljevic A, Myers RM, Park PJ, Pazin MJ, Perry MD, Raha D, Reddy TE, Rozowsky J, Shoresh N, Sidow A, Slattery M, Stamatoyannopoulos JA, Tolstorukov MY, White KP, Xi S, Farnham PJ, Lieb JD, Wold BJ, Snyder M. 2012. ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia. Genome Res 22:1813-1831. http://dx.doi.org/10.1101/gr.136184.111.
50. Mali P, Esvelt KM, Church GM. 2013. Cas9 as a versatile tool for engineering biology. Nat Methods 10:957-963. http://dx.doi.org/10.1038/nmeth.2649.
51. Villablanca EJ, Raccosta L, Zhou D, Fontana R, Maggioni D, Negro A, Sanvito F, Ponzoni M, Valentinis B, Bregni M, Prinetti A, Steffensen KR, Sonnino S, Gustafsson JA, Doglioni C, Bordignon C, Traversari C, Russo V. 2010. Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses. Nat Med 16:98-105. http://dx.doi.org/10.1038/nm.2074.
52. Chen W, Chen G, Head DL, Mangelsdorf DJ, Russell DW. 2007. Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice. Cell Metab 5:73-79. http://dx.doi.org/10.1016/j.cmet.2006.11.012.
53. Hong C, Tontonoz P. 2014. Liver X receptors in lipid metabolism: opportunities for drug discovery. Nat Rev Drug Discov 13:433-444. http://dx.doi.org/10.1038/nrd4280.
54. Choi JH, Banks AS, Kamenecka TM, Busby SA, Chalmers MJ, Kumar N, Kuruvilla DS, Shin Y, He Y, Bruning JB, Marciano DP, Cameron MD, Laznik D, Jurczak MJ, Schurer SC, Vidovic D, Shulman GI, Spiegelman BM, Griffin PR. 2011. Antidiabetic actions of a non-agonist PPARgamma ligand blocking Cdk5-mediated phosphorylation. Nature 477:477-481. http://dx.doi.org/10.1038/nature10383.
55. Amato AA, Rajagopalan S, Lin JZ, Carvalho BM, Figueira AC, Lu J, Ayers SD, Mottin M, Silveira RL, Souza PC, Mourao RH, Saad MJ, Togashi M, Simeoni LA, Abdalla DS, Skaf MS, Polikparpov I, Lima MC, Galdino SL, Brennan RG, Baxter JD, Pitta IR, Webb P, Phillips KJ, Neves FA. 2012. GQ-16, a novel peroxisome proliferator-activated receptor gamma (PPARgamma) ligand, promotes insulin sensitization without weight gain. J Biol Chem 287:28169-28179. http://dx.doi.org/10.1074/jbc.M111.332106.